Double blind, randomized controlled study to evaluate the efficacy and safety of extract of leaves of Dendropanax morbiferous H. Lev on the glucose metabolism

Kyung Hee University Hosipital at Gangdong0 个研究点目标入组 80 人开始时间: 待定最近更新: 2020年2月24日

试验速览

暂无简介。

•1) 80 male and female adults aged 21 to 75 years without diabetes with fasting blood glucose levels below 126 mg / dl and glycated hemoglobin less than 6.5%
•2) Person who has not received drug treatment for obesity and diabetes in the last three months
•3) The person who voluntarily agreed to participate in this clinical trial

•1) Fasting blood glucose is 126 mg / dl or more or HbA1C 6.5% or more
•2) Those who are taking drugs or dietary supplements for diabetes within the last three months and during clinical trials
•3) Mental illnesses that may affect subject evaluation and investigational drugs. In particular, history such as mental disorder, depression
•4) Except where the following laboratory test results are shown, which may affect the performance of the test.
•AST (SGOT) / ALT (SGPT) is a liver disease that is more than three times the normal upper limit
•-Renal impairment with creatinine levels above 1.5 mg / dl
•5) Those who have been taking glucocorticoids that affect blood sugar within the last 3 months
•6) Drug abuser or historical person (including alcohol)
•7) History of serious illness that can recur during or immediately after clinical trials
•8) Those who need treatment due to hyperthyroidism or hypothyroidism. (However, hypothyroidism that does not require treatment with a TSH of less than 10 µg / dl is not applicable.)
•In addition, persons deemed impossible to participate in clinical research by researchers

发起方

Kyung Hee University Hosipital at Gangdong